21.6 C
New York

Tag: iShares Biotechnology ETF

FDA approves daily HIV pill from Gilead designed to simplify treatment for some patients

Health
The Food and Drug Administration approved a once-daily HIV pill from Gilead that could help simplify care for some patients, the company announced Thursday. The...

The market for psychedelic drugs to treat mental health conditions gets a big buy signal

Health
Psilocybin mushrooms stand ready for harvest in a humidified "fruiting chamber." John Moore | Getty ImagesThursday's announcement that Eli Lilly will acquire AtaiBeckley, a...

Jim Cramer says this former Covid market darling is finally investable again

Health
Moderna's expanding pipeline beyond infectious diseases is giving investors a new reason to own the stock after years of uncertainty following the Covid-19 pandemic,...

CDC says American tests positive for Ebola in Africa, risk in the U.S. remains low

Business
A sign sits outside of the Centers for Disease Control and Prevention (CDC) Roybal campus in Atlanta, Georgia, U.S. March 18, 2026. Megan Varner...

Hantavirus cases spark brief surge in pharma and biotech stocks — here’s why trading is so volatile

Health
ILLUSTRATION of hantavirus testing concept with laboratory tubes containing cotton swabs and HANTAVIRUS labels photographed in front of a public domain hantavirus related microscopic...

Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss

Health
Thomas Fuller | Nurphoto | Getty ImagesPfizer on Monday said it will seek regulatory approval for a Lyme disease vaccine candidate despite the shot...

Vertex passes key test in quest to treat kidney diseases

Health
A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston.Brian Snyder | ReutersVertex Pharmaceuticals said its experimental drug for a...

Recent articles

spot_img
Premium Content

© GoodNews All rights reserved